Author Archives for admin
October 23, 2020 4:53 pm Published by admin Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma William D. Tap, MD1,2; Victor M. Villalobos, MD, PhD3; Gregory M. Cote, MD, PhD4; Howard Burris, MD5; Filip Janku, MD, PhD6; Olivier Mir, MD, MPH, PhD7; Murali Beeram, MD8; Andrew J. Wagner, MD, PhD9; Liewen Jiang, PhD10; [...]
October 21, 2020 8:08 pm Published by admin Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells Luyuan Li, Ana C. Paz, Breelyn A. Wilky, Britt Johnson, Karina Galoian, Andrew Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C. Trent Jonathan Trent, M.D., Ph.D. is a world renown leader of [...]
October 20, 2020 6:13 pm Published by admin Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma Specialists: On Tuesday, November 17, 2020 from 7:30pm -8:30pm EST, the Chondrosarcoma CS Foundation, Inc. will host a virtual dialogue using the zoom platform to reach [...]
October 19, 2020 5:53 pm Published by admin The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase Gabriel Tinoco, MD, Breelyn A. Wilky, MD, Ana Paz-Mejia, MS, Andrew Rosenberg, MD, Jonathan C. Trent, MD, PhD Jonathan Trent, M.D., Ph.D. is a world renown leader of the Sarcoma, Associate Director, Clinical Research, University of Miami, Sylvester Comprehensive Cancer Center, he [...]
October 16, 2020 10:04 pm Published by admin Sarcomas: Evidence-Based Diagnosis and Management Jonathan C. Trent, Andrew E. Rosenberg, Raphael Pollock, Thomas F. Delaney Springer Publishing Company, Incorporated, 2020 – Medical – 434 pages Jonathan Trent, M.D.,Ph.D. is the leader of the Sarcoma Disease Group, Associate Director, Clinical Research, University of Miami, Sylvester Comprehensive Cancer Center, he currently runs a research lab and [...]
October 15, 2020 7:47 pm Published by admin Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma Specialists: On Tuesday, November 17, 2020 from 7:30pm -8:30pm EST, the Chondrosarcoma CS Foundation, Inc. will host a virtual dialogue using the zoom platform to reach [...]
October 12, 2020 5:24 pm Published by admin Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm Easter Standard Time For CS Warriors who have been newly diagnosed, for CS Warriors that have been diagnosed with a reoccurrence of Chondrosarcoma, for CS Warriors who are told their recurrence is inoperable, for those few lucky CS Warriors [...]
October 9, 2020 4:14 am Published by admin Bone Cancer Awareness Week 2020 12 – 18 October 2020 76% of primary bone cancer cases in the UK are misdiagnosed. #BoneCancerAwareness Week 2020 is all about educating GPs, Radiologists, Physiotherapists, Pharmacists and Medical Students about the signs and symptoms of primary bone cancer, alongside raising vital awareness amongst the general public. Read on to [...]
October 5, 2020 2:00 am Published by admin Free educational webinars for healthcare professionals Register for our free webinars now. 76% of primary bone cancer cases in the UK are misdiagnosed. Throughout Bone Cancer Awareness Week (12 – 18 Oct) we are holding a series of FREE webinars, specifically designed to increase understanding and knowledge of the signs and symptoms of primary bone [...]
October 1, 2020 5:46 pm Published by admin Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm EST 1. Progress Report: So far we have 38 Chondrosarcoma Warrior’s and their families registered and many of the registrant’s have submitted their questions in advance. We received 26 questions. Some questions were personal and had some sense of [...]
